Rituximab efficiently depletes B cells in lung tumors and normal lung tissue.
Joly-Battaglini A, Hammarström C, Stankovic B, Aamodt H, Stjärne J, Brustugun OT, Helland Å, Øynebråten I, Corthay A.
Joly-Battaglini A, et al. Among authors: helland a.
F1000Res. 2016 Jan 8;5:38. doi: 10.12688/f1000research.7599.1. eCollection 2016.
F1000Res. 2016.
PMID: 27081474
Free PMC article.